Z
Zainab Siddiqui
Publications - 5
Citations - 60
Zainab Siddiqui is an academic researcher. The author has contributed to research in topics: Biology & Internal medicine. The author has an hindex of 2, co-authored 2 publications receiving 26 citations.
Papers
More filters
Journal ArticleDOI
Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms
Mohsin Ali Khan,Zaw Ali Khan,Mark Rector Charles,Pushpendra Pratap,Abdul Naeem,Zainab Siddiqui,Nigar Naqvi,Shikha Srivastava +7 more
TL;DR: In this paper, the role of cytokine storm in inducing sudden mucus hypersecretion in COVID-19 was discussed and active constituents that inhibit or activate several potential targets are outlined for further research.
Journal ArticleDOI
Anticancer Potential of Dietary Natural Products: A Comprehensive Review.
Rumana Ahmad,Mohsin Ali Khan,Anvesha Srivastava,Anamika Gupta,Aditi Srivastava,Tanvir R Jafri,Zainab Siddiqui,Sunaina Chaubey,Tahmeena Khan,Arvind K. Srivastava +9 more
TL;DR: The present review provides a comprehensive and collective update on the potential of 65 commonly used spices as well as their bioactive constituents as anticancer agents.
Journal ArticleDOI
DIFFERENTIAL EXPRESSION OF MICRORNAs IN LUNG CANCER: A REVIEW ARTICLE
TL;DR: A review article focuses on the diagnostic significance of miRNAs in Lung cancer, which shows differential expression pattern i.e. may be either upregulated or downregulated.
Journal ArticleDOI
Association of the circulating micro-RNAs with susceptible and newly diagnosed type 2 diabetes mellitus cases
S Raza,Saliha Rizvi,Sheeba Afreen,Sanchit Srivastava,Zainab Siddiqui,Naseem Fatima,Zeba Siddiqi,Farzana Mahdi +7 more
TL;DR: In this article , the authors evaluated the T2DM-related miRNAs miRNA-126, miR-486, miRN-223, miRNA -223 and miRNA −375 in newly diagnosed Type II Diabetes mellitus (T2DM) susceptible and healthy control individuals.
Journal ArticleDOI
Expression of cd44 as a cancer stem cell marker in oral cancer: a meta-analysis study
TL;DR: It is suggested that higher tumor expression of CD44 may predict poor survival in end staged OC patient, and positive expression ofCD44 in advanced stages was prominently associated with reduced survival rate.